KNOW Bio appoints senior executive
Ms. Whitaker is a seasoned bio-pharmaceutical leader with over 25 years of experience in the life science industry including senior leadership roles with large pharmaceutical, biotech and specialty pharmaceutical companies.
Ms. Whitaker joins KNOW Bio from Valeant where she was Executive Vice President, Company Group Chairman for the past 18 months overseeing the Branded Pharmaceutical businesses.
Prior to Valeant, Ms. Whitaker was the President and CEO of Synta Pharmaceuticals, a development stage oncology company which is now part of Madrigal Pharmaceuticals, Inc.
Previous to her experience as CEO, Ms. Whitaker served as President of North America Pharmaceuticals at Sanofi where she oversaw all pharmaceutical and consumer healthcare operations for the region.
She also held several commercial leadership roles at GlaxoSmithKline. ■
LATEST MOVES FROM North Carolina
- Bojangles’ appoints Robert F. Hull, Jr. to board
- Nucor elects General Lloyd J. Austin III (Ret) as director
- Jeld-Wen Holding appoints William Banholzer to board
- QuintilesIMS appoints Colleen Goggins to board
- G1 Therapeutics appoints Sir Andrew Witty to board
More inside POST